captopril has been researched along with Disease Exacerbation in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (34.62) | 18.2507 |
| 2000's | 17 (32.69) | 29.6817 |
| 2010's | 16 (30.77) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, G; Bandiera, S; Barrett, SC; Baumert, TF; Chung, RT; Crouchet, E; Del Zompo, F; Durand, SC; El Saghire, H; Felli, E; Fuchs, BC; Fujiwara, N; Ghoshal, S; Giannone, F; Hoshida, Y; Li, S; Lupberger, J; Oudot, MA; Pessaux, P; Pochet, N; Ponsolles, C; Qian, T; Rasha, FA; Schaeffer, E; Schuster, C; Slovic, N; Sojoodi, M; Tanabe, KK; Van Renne, N; Zhu, S | 1 |
| Jesson, MI; Nikolic-Paterson, DJ; Pullen, N; Schlerman, FJ; Tesch, GH | 1 |
| Arellano-Mendoza, MG; Del Valle-Mondragón, L; Guevara-Salazar, JA; Montes-Rivera, JO; Quintana-Pérez, JC; Tamay-Cach, F; Trujillo-Ferrara, JG | 1 |
| Aronow, B; Cancelas, JA; Chang, KH; Eiymo Mwa Mpollo, MS; Inagami, T; Malik, P; Rai, P; Rizvi, T; Roy, S; Shanmukhappa, SK; VandenHeuvel, K | 1 |
| Negandhi, A; Smeda, JS; Stuckless, J; Watson, D | 1 |
| Fukushima, N; Horiba, N; Maeda, A; Miyamoto, KI; Segawa, H | 1 |
| Hiraga, S; Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Takahashi, S; Tanabe, C; Terayama, Y; Watanabe, A; Zou, K | 1 |
| Bai, X; Chai, R; Guo, W; Han, Y; Li, J; Wang, H; Xu, L; Yan, W | 1 |
| Awad, AS; Cooper, TK; Gao, T; Morris, SM; You, H | 1 |
| Awad, AS; Cooper, TK; Gao, T; Gvritishvili, A; Tombran-Tink, J; You, H | 1 |
| Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z; Naumovic, R | 1 |
| Baradaran, HR; Khamseh, ME; Safarnejad, B | 1 |
| Kang, HS; Kim, JS; Kim, SJ; Kim, SZ; Lee, YU; Rahman, M | 1 |
| Ito, Y; Karashima, S; Takeda, R; Takeda, Y; Yamamoto, Y; Yoneda, T | 1 |
| Alves Meira, ZM; Araújo, FA; Brandão, KN; Rocha Araújo, FD; Vasconcelos Severiano, GM | 1 |
| Amigoni, M; Califf, R; Køber, L; Levine, RA; McMurray, JJ; Meris, A; Pfeffer, MA; Solomon, SD; Thune, JJ; Velazquez, E; Verma, A | 1 |
| Burnier, M; Martin, PY | 1 |
| Deng, JL; Hou, YB; Li, J; Song, H; Wang, H; Yue, J | 1 |
| Dickinson, BA; Hullinger, TG; Latimer, PA; Lewton, SM; Lynch, JM; Montgomery, RL; Semus, HM; Seto, AG; Stack, C; van Rooij, E | 1 |
| Suzuki, H | 1 |
| Boggia, J; Ferreiro, A; Gadola, L; García, S; Márquez, MN; Musto, ML; Nin, N; Noboa, O; Ortega, V; Pizarrosa, C; Ponte, P; Ravaglio, S; Rodriguez, MJ; Sesser, P; Vallega, A | 1 |
| Grabensee, B; Mödder, U; Sandmann, W; Schmitz, M; Voiculescu, A | 1 |
| Aldington, SJ; Holman, RR; Kohner, EM; Matthews, DR; Stratton, IM | 1 |
| Gupta, S; Sen, S; Young, D | 1 |
| Starr, JM; Whalley, LJ | 1 |
| Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z | 1 |
| Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA | 1 |
| Batyraliev, TA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Andrade, RJ; Barriocanal, A; Borraz, Y; Costa, J; Durán, JA; Fernández, MC; García-Cortés, M; García-Muņoz, B; Guarner, C; Hidalgo, R; Kaplowitz, N; Lucena, MI; Muņoz-Yagüe, T; Pachkoria, K; Pelaez, G; Planas, R; Rodrigo, L; Romero-Gomez, M; Salmerón, J | 1 |
| Guillevin, L; Mehrenberger, M; Mouthon, L; Noël, LH; Servettaz, A; Teixeira, L | 1 |
| Gans, DJ; Laffel, LM; McGill, JB | 1 |
| Materson, BJ | 1 |
| Ambrosioni, E; Borghi, C; Magnani, B | 1 |
| Kimmel, PL; Mishkin, GJ; Umana, WO | 1 |
| Cambien, F; Jacobsen, P; Lecerf, L; Parving, HH; Poirier, O; Rossing, P; Tarnow, L | 1 |
| Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Bagust, A; Hendry, BM; Hummel, S; Piercy, J; Viberti, GC | 1 |
| Arrojo Arias, E; Cordero Guevara, J; del Saz Moreno, V; González Castro, ML; Sáez Fernández, A; Sagredo Pérez, J | 1 |
| Krakoff, LR; Rajasekharaiah, V | 1 |
| Ballerio, R; Barberi, L; Bolla, M; Catapano, AL; Ferioli, R; Folco, G; Hernandez, A; Natali, M; Testini, A | 1 |
| Hricik, DE; Justice, AC; Rodby, RA; Weiss, MF | 1 |
| Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Parving, HH | 1 |
| Gerasimenko, OI; Kutyrina, IM; Shvetsov, MIu; Tareeva, IE | 1 |
| Benatar, D; Gheorghiade, M; Hall, V; Reddy, S | 1 |
| Bain, RP; Blumenthal, S; Cattran, D; Hebert, LA; Levey, AS; Lewis, EJ; Lewis, JB; Rohde, RD; Spitalewitz, S; Whittier, F; Wilmer, WA | 1 |
| Torffvit, O | 1 |
| Lohmeier, TE; Mizelle, HL; Montani, JP; Reinhart, GA | 1 |
| Walls, J | 1 |
| Fujisawa, K; Hiraoka, M; Hori, C; Mayumi, M; Ohshima, Y; Tsukahara, H; Tsuzuki, K; Yoshida, Y; Yoshikawa, N; Yoshioka, K | 1 |
7 review(s) available for captopril and Disease Exacerbation
| Article | Year |
|---|---|
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Humans; Kidney Failure, Chronic; Medicine, Chinese Traditional; Phytotherapy; Rheum | 2012 |
[Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Clinical Trials as Topic; Disease Progression; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Tetrazoles; Treatment Outcome | 2002 |
[Vascular stenosis after kidney transplantation with influence on blood pressure and renal function].
Topics: Acute Kidney Injury; Angiography; Angiography, Digital Subtraction; Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Disease Progression; Humans; Hypertension, Renovascular; Kidney Function Tests; Kidney Transplantation; Magnetic Resonance Angiography; Models, Theoretical; Radionuclide Imaging; Recurrence; Renal Artery Obstruction; Sensitivity and Specificity; Stents; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2004 |
[Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Time Factors; Treatment Outcome | 2006 |
[Scleroderma renal crisis].
Topics: Acute Kidney Injury; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biopsy; Calcium Channel Blockers; Captopril; Diagnosis, Differential; Disease Progression; Female; Humans; Hypertension, Pulmonary; Hypertension, Renal; Kidney; Male; Oliguria; Pregnancy; Pregnancy Complications; Prognosis; Renal Replacement Therapy; Risk; Risk Factors; Scleroderma, Diffuse; Scleroderma, Systemic; Time Factors; Ultrasonography, Doppler | 2006 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Risk Factors | 1998 |
11 trial(s) available for captopril and Disease Exacerbation
| Article | Year |
|---|---|
Myocardial calcification and hypertension following chronic renal failure and ameliorative effects of furosemide and captopril.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Calcinosis; Captopril; Cardiomyopathies; Disease Models, Animal; Disease Progression; Diuretics; Drug Therapy, Combination; Euthanasia, Animal; Furosemide; Hemodynamics; Hypertension; Kidney Failure, Chronic; Male; Myocardium; Nephrectomy; Rats; Rats, Sprague-Dawley | 2010 |
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Monitoring, Physiologic; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Reference Values; Reproducibility of Results; Risk Assessment; ROC Curve; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cataract Extraction; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypertension, Renal; Laser Coagulation; Male; Middle Aged; Prospective Studies; Risk Factors; Vision Disorders; Vitreous Hemorrhage | 2004 |
Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Captopril; Cognition; Disease Progression; Female; Humans; Hypertension; Male; Memory; Neuropsychological Tests; Psychomotor Performance; Treatment Outcome; United Kingdom | 2005 |
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2005 |
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1995 |
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Topics: Adolescent; Adult; Age of Onset; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Placebos; Proportional Hazards Models; Regression Analysis; Risk Assessment; Time Factors | 1996 |
Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prevalence; Prospective Studies; Time Factors | 1996 |
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Captopril; Creatinine; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lysine; Male; Neopterin; Predictive Value of Tests; Survival Analysis | 1998 |
[Hemodynamic mechanisms of lupus nephritis progression].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Female; Hemodynamics; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Prognosis; Ramipril | 1998 |
Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiotonic Agents; Digoxin; Disease Progression; Diuretics; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Neurosecretory Systems; Nicardipine; Norepinephrine; Renin; Severity of Illness Index; Stroke Volume; Treatment Outcome | 1998 |
34 other study(ies) available for captopril and Disease Exacerbation
| Article | Year |
|---|---|
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinogenesis; Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; ErbB Receptors; Liver Cirrhosis; Liver Neoplasms; Peptidyl-Dipeptidase A; Rats; Transcriptional Activation | 2022 |
Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Azabicyclo Compounds; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Hypertension, Renal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Podocytes; Pyrimidines; Receptors, CCR2 | 2019 |
Apocynin combined with drugs as coadjuvant could be employed to prevent and/or treat the chronic kidney disease.
Topics: Acetophenones; Adjuvants, Pharmaceutic; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; Disease Models, Animal; Disease Progression; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Humans; Losartan; Mice; Mice, Inbred C57BL; Oxidative Stress; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy.
Topics: Adult; Anemia, Sickle Cell; Angiotensin II Type 1 Receptor Blockers; Animals; Captopril; Child; Disease Progression; Humans; Kidney Concentrating Ability; Kidney Diseases; Losartan; Mice; Protective Agents; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction | 2018 |
Post-stroke losartan and captopril treatments arrest hemorrhagic expansion in SHRsp without lowering blood pressure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Edema; Captopril; Cerebral Hemorrhage; Cerebrum; Disease Models, Animal; Disease Progression; Losartan; Male; Rats, Inbred WKY; Renin-Angiotensin System; Serum Albumin; Stroke; Time Factors | 2018 |
The Role of Extracellular Phosphate Levels on Kidney Disease Progression in a Podocyte Injury Mouse Model.
Topics: Animals; Calcium; Captopril; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Kidney Tubules; Klotho Proteins; Male; Mice; Parathyroid Hormone; Phosphates; Podocytes; Renal Insufficiency, Chronic; RNA, Messenger; Sevelamer | 2019 |
Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Brain; Captopril; Case-Control Studies; Disease Progression; Humans; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Presenilins | 2013 |
Combining use of captopril and losartan attenuates the progress of Streptococcus pneumoniae-induced tympanosclerosis through the suppression of TGF-β1 expression.
Topics: Animals; Blotting, Western; Calcinosis; Calcium; Captopril; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Ear, Middle; Guinea Pigs; Hearing; Immunohistochemistry; Losartan; Male; Mucous Membrane; Myringosclerosis; Rats, Wistar; Streptococcus pneumoniae; Transforming Growth Factor beta1 | 2014 |
Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginase; Boronic Acids; Captopril; Diabetic Nephropathies; Disease Progression; Kidney; Mice; Nitric Oxide Synthase Type III; Phosphorylation; Treatment Outcome | 2015 |
Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
Topics: Animals; Blood Pressure; Captopril; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Eye Proteins; Kidney; Macrophages; Male; Membrane Proteins; Mice; Nerve Growth Factors; Serpins | 2015 |
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Carbazoles; Carvedilol; Creatinine; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Kidney Failure, Chronic; Propanolamines; Proteinuria; Rats; Rats, Inbred SHR; Time Factors | 2009 |
The effect of captopril on progression of retinopathy in type 2 diabetes.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Captopril; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis | 2009 |
Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Chi-Square Distribution; Comorbidity; Disease Progression; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mass Screening; Middle Aged; Prehypertension; Prevalence; Severity of Illness Index; Statistics, Nonparametric | 2011 |
Cardiac tamponade as a rare form of presentation of rheumatic carditis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antihypertensive Agents; Captopril; Cardiac Tamponade; Child; Disease Progression; Diuretics; Female; Furosemide; Gentamicins; Humans; Oxacillin; Penicillin G Benzathine; Pericardiocentesis; Prednisone; Protein Synthesis Inhibitors; Rheumatic Fever; Rheumatic Heart Disease | 2010 |
[Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Drug Delivery Systems; Drug Interactions; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System; Risk Assessment | 2012 |
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Captopril; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Heart Failure; Hypertension; Male; MicroRNAs; Natriuretic Peptide, Brain; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Sodium Chloride; Treatment Outcome | 2013 |
Calcium citrate ameliorates the progression of chronic renal injury.
Topics: Alkalies; Animals; Bicarbonates; Calcium Citrate; Captopril; Cell Division; Disease Progression; Drug Combinations; Immunohistochemistry; Inulin; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Tubules; Male; Nephrectomy; Proteinuria; Random Allocation; Rats; Rats, Wistar | 2004 |
Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Disease Progression; Hydralazine; Hypertension; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Organ Size; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiocarbamates; Vasodilator Agents | 2005 |
Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Animals; Antibiotics, Antineoplastic; Antihypertensive Agents; Blood Pressure; Captopril; Carbazoles; Carvedilol; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Kidney Failure, Chronic; Nephritis; Propanolamines; Rats; Rats, Inbred SHR | 2005 |
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Captopril; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Heart Failure; Humans; Hypokalemia; Hypotension; Losartan; Meta-Analysis as Topic; Myocardial Infarction; Renal Insufficiency; Tetrazoles; Valine | 2005 |
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Atorvastatin; Azepines; Captopril; Cardiovascular Agents; Central Nervous System Agents; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Heptanoic Acids; Humans; Liver; Liver Diseases; Male; Middle Aged; Pyrroles; Registries; Spain | 2006 |
ACE inhibitors as a shield against diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Humans; Kidney Failure, Chronic | 1996 |
Captopril and renal survival in patients with human immunodeficiency virus nephropathy.
Topics: Adult; AIDS-Associated Nephropathy; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Captopril; Disease Progression; Drug Evaluation; Female; HIV-1; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Survival Analysis; Time Factors | 1996 |
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Topics: Adult; Albuminuria; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Gene Deletion; Genotype; Glomerular Filtration Rate; Heterozygote; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome | 1996 |
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 1997 |
Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; England; Health Care Costs; Humans; Kidney Failure, Chronic; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1997 |
[The effects of long-term captopril treatment on the evolution of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus].
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Prevalence; Time Factors | 1997 |
Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Captopril; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Data Interpretation, Statistical; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypercholesterolemia; Indans; Male; Nitric Oxide; Nitroglycerin; Norepinephrine; Rabbits; Triglycerides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides | 1998 |
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies; Proteinuria; Randomized Controlled Trials as Topic; Remission Induction | 1999 |
Diabetic nephropathy: what causes to treat?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetic Nephropathies; Disease Progression; Humans; Hypertension; Kidney; Prognosis | 1999 |
Influence of angiotensin on the early progression of heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Proteins; Captopril; Cardiac Output, Low; Cardiac Pacing, Artificial; Disease Progression; Dogs; Electrolytes; Hematocrit; Hemodynamics; Male; Neurotransmitter Agents; Renal Circulation; Sodium Chloride; Water-Electrolyte Balance | 2000 |
Relationship between proteinuria and progressive renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diet, Protein-Restricted; Disease Progression; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Proteinuria | 2001 |
Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Benzazepines; Captopril; Child; Disease Progression; Drug Resistance; Enalapril; Female; Glomerulosclerosis, Focal Segmental; Humans; Incidence; Japan; Kidney Failure, Chronic; Male; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Regression Analysis; Retrospective Studies; Survival Rate | 2001 |